特宝生物
(688278)
| 流通市值：349.28亿 | | | 总市值：349.28亿 |
| 流通股本：4.07亿 | | | 总股本：4.07亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 528,973,264.73 | 528,072,404.71 | 371,821,698.43 | 333,254,167.74 |
| 交易性金融资产 | 150,590,535.23 | 290,040,457.03 | 289,963,952.73 | 251,293,715.4 |
| 应收票据及应收账款 | 752,103,323.47 | 695,961,143.22 | 808,524,408.19 | 577,913,926.23 |
| 其中：应收票据 | 116,918,551.61 | 41,937,547.98 | 37,027,868.8 | 27,059,360.06 |
| 应收账款 | 635,184,771.86 | 654,023,595.24 | 771,496,539.39 | 550,854,566.17 |
| 预付款项 | 85,322,794.7 | 57,044,322.07 | 38,768,166.49 | 56,880,697.92 |
| 其他应收款合计 | 29,242,224.31 | 30,746,025.01 | 21,976,854.03 | 35,872,420.44 |
| 存货 | 321,192,181.1 | 285,459,731.42 | 263,546,426.51 | 252,749,398.6 |
| 一年内到期的非流动资产 | - | 30,739,961.61 | 30,739,961.61 | - |
| 其他流动资产 | 2,255,026.99 | 1,965,684.73 | 1,748,697.09 | 1,587,135.49 |
| 流动资产合计 | 1,869,679,350.53 | 1,920,029,729.8 | 1,827,090,165.08 | 1,509,551,461.82 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 56,762,884.93 | 56,762,884.93 | 56,762,884.93 | 58,035,623.14 |
| 固定资产 | 518,267,612.47 | 505,675,672.1 | 496,526,291.01 | 322,369,811.89 |
| 在建工程 | 249,974,576.13 | 205,692,374.48 | 181,556,607.69 | 304,445,296.16 |
| 使用权资产 | 18,619,834.74 | 8,019,873.39 | 8,672,242.34 | 9,716,112.2 |
| 无形资产 | 294,393,826.7 | 162,616,332.68 | 170,848,518.3 | 179,073,372.45 |
| 开发支出 | 94,002,988.54 | 219,331,253.38 | 208,891,692.66 | 192,881,019.38 |
| 长期待摊费用 | 13,458,946.41 | 16,696,611.14 | 12,308,008.65 | 17,757,977.77 |
| 递延所得税资产 | 72,211,811.25 | 67,153,969.26 | 69,089,875.09 | 42,975,772.92 |
| 其他非流动资产 | 21,995,262.86 | 17,144,935.22 | 18,668,549.83 | 46,509,166.73 |
| 非流动资产合计 | 1,339,687,744.03 | 1,259,093,906.58 | 1,223,324,670.5 | 1,173,764,152.64 |
| 资产总计 | 3,209,367,094.56 | 3,179,123,636.38 | 3,050,414,835.58 | 2,683,315,614.46 |
| 流动负债: | | | | |
| 短期借款 | 9,904,541.66 | 9,867,888.89 | - | - |
| 应付票据及应付账款 | 87,785,897.27 | 56,854,318.01 | 60,140,756.18 | 56,355,580.81 |
| 应付账款 | 87,785,897.27 | 56,854,318.01 | 60,140,756.18 | 56,355,580.81 |
| 合同负债 | 57,803,454.62 | 62,185,572.95 | 63,126,041.07 | 62,140,015.12 |
| 应付职工薪酬 | 127,393,719.18 | 128,557,201.84 | 178,478,291.24 | 131,297,684.32 |
| 应交税费 | 31,443,277.65 | 43,556,634.63 | 69,764,523.07 | 56,117,089.22 |
| 其他应付款合计 | 40,298,995.85 | 39,290,501.47 | 43,327,949.37 | 38,813,361.46 |
| 一年内到期的非流动负债 | 5,101,650.92 | 5,045,358.15 | 5,668,516.94 | 4,452,043.69 |
| 其他流动负债 | 61,596.9 | 144,364.65 | 123,387.32 | 126,732.08 |
| 流动负债合计 | 359,793,134.05 | 345,501,840.59 | 420,629,465.19 | 349,302,506.7 |
| 非流动负债: | | | | |
| 租赁负债 | 14,142,678.24 | 3,256,774.77 | 3,268,065.07 | 5,450,600.99 |
| 预计负债 | 40,171,769.09 | 39,648,016.18 | 39,305,813.52 | 28,633,447.41 |
| 递延收益 | 38,887,491.6 | 40,555,586.47 | 32,961,392.76 | 34,467,452.68 |
| 递延所得税负债 | 985,159.73 | 877,206.61 | 933,807.29 | 913,646.15 |
| 非流动负债合计 | 94,187,098.66 | 84,337,584.03 | 76,469,078.64 | 69,465,147.23 |
| 负债合计 | 453,980,232.71 | 429,839,424.62 | 497,098,543.83 | 418,767,653.93 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 406,800,000 | 406,800,000 | 406,800,000 | 406,800,000 |
| 资本公积 | 439,532,136.03 | 426,978,680.26 | 413,139,677.14 | 397,824,362 |
| 盈余公积 | 182,952,982.18 | 182,952,982.18 | 182,952,982.18 | 117,548,442.81 |
| 未分配利润 | 1,726,101,743.64 | 1,732,552,549.32 | 1,550,423,632.43 | 1,342,375,155.72 |
| 归属于母公司股东权益合计 | 2,755,386,861.85 | 2,749,284,211.76 | 2,553,316,291.75 | 2,264,547,960.53 |
| 股东权益合计 | 2,755,386,861.85 | 2,749,284,211.76 | 2,553,316,291.75 | 2,264,547,960.53 |
| 负债和股东权益合计 | 3,209,367,094.56 | 3,179,123,636.38 | 3,050,414,835.58 | 2,683,315,614.46 |
| 公告日期 | 2025-08-21 | 2025-04-23 | 2025-03-28 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |